ICare Self-tonometry - A Head-to-head Comparison to the Gold Standard Goldmann Tonometer

NCT ID: NCT01733550

Last Updated: 2012-11-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-11-30

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare glaucoma patients' own I Care measurements by the standard Goldmann applanation tonometer intraocular pressure (IOP) measurements.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

not necessary

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Intraocular Pressure Tonometry, Ocular iCare

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Glaucoma patients

Intraocular pressure is measured by Home iCare performed by the study nurse, by the patient it self and by Goldmann applanation tonometry.

Home iCare (study nurse)

Intervention Type DEVICE

the intraocular pressure is measured by iCare performed by the study nurse

goldmann applanation tonometry

Intervention Type DEVICE

the intraocular pressure is measured by goldmann applanation tonometry

home iCare (by patient)

Intervention Type DEVICE

the intraocular pressure is measured by the iCare performed by the patient him self

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Home iCare (study nurse)

the intraocular pressure is measured by iCare performed by the study nurse

Intervention Type DEVICE

goldmann applanation tonometry

the intraocular pressure is measured by goldmann applanation tonometry

Intervention Type DEVICE

home iCare (by patient)

the intraocular pressure is measured by the iCare performed by the patient him self

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ocular hypertension (OHT):with/without glaucoma drugs
* Primary open angle glaucoma (POAG)- high pressure: Diagnosis based on optic nerve head rim loss and/or visual field defects and intraocular pressure (IOP) \>21 mmHg.
* Primary open angle glaucoma, normal pressure: cfr high pressure but intraocular pressure ≤ 21 mmHg
* Exfoliative Glaucoma (PEX): Diagnosis based on optic nerve head rim loss and/or visual field defects and intraocular pressure (IOP) \>21 mmHg, with exfoliation material in the anterior segment.
* Pigmentary Glaucoma (PDG): Diagnosis based on optic nerve head rim loss and/or visual field defects and intraocular pressure (IOP) \>21 mmHg, with Krukenberg's spindle and/or pigment dispersed on the trabecular meshwork.

Exclusion Criteria

* Age \<18 years
* Other glaucoma types
* Corneal pathology (edema, dystrophia, corneal transplantation, severe keratoconus, permanent contact lens wear, recurrent corneal erosion)
* Severe arthritis (unable to handle home i care device)
* Lack of comprehension
* Intra ocular surgery and laser treatment during the last 6 months
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitaire Ziekenhuizen KU Leuven

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ingeborg Stalmans

Role: PRINCIPAL_INVESTIGATOR

Universitaire Ziekenhuizen KU Leuven

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UZLeuven

Leuven, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sien Boons, Optometrist

Role: CONTACT

Phone: +32-16-33-23-61

Email: [email protected]

Evelien Dewilde, Resident

Role: CONTACT

Phone: +32-16-33-23-61

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sien Boons, Optometrist

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

s54640

Identifier Type: -

Identifier Source: org_study_id